vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and Life Time Group Holdings, Inc. (LTH). Click either name above to swap in a different company.
Life Time Group Holdings, Inc. is the larger business by last-quarter revenue ($788.7M vs $451.8M, roughly 1.7× HALOZYME THERAPEUTICS, INC.). Life Time Group Holdings, Inc. runs the higher net margin — 11.2% vs -31.3%, a 42.5% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 11.7%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $-61.2M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 8.7%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Life Time Group Holdings, Inc. operates a network of premium athletic, fitness and wellness destinations across the United States. It offers diverse services including state-of-the-art gym facilities, group exercise classes, personal training, spa treatments, nutrition coaching, youth programs and co-working spaces for consumers pursuing holistic healthy lifestyles.
HALO vs LTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $788.7M |
| Net Profit | $-141.6M | $88.1M |
| Gross Margin | 82.6% | — |
| Operating Margin | -20.6% | 17.1% |
| Net Margin | -31.3% | 11.2% |
| Revenue YoY | 51.6% | 11.7% |
| Net Profit YoY | -203.3% | 15.8% |
| EPS (diluted) | $-1.13 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $788.7M | ||
| Q4 25 | $451.8M | $745.1M | ||
| Q3 25 | $354.3M | $782.6M | ||
| Q2 25 | $325.7M | $761.5M | ||
| Q1 25 | $264.9M | $706.0M | ||
| Q4 24 | $298.0M | $663.3M | ||
| Q3 24 | $290.1M | $693.2M | ||
| Q2 24 | $231.4M | $667.8M |
| Q1 26 | — | $88.1M | ||
| Q4 25 | $-141.6M | $123.0M | ||
| Q3 25 | $175.2M | $102.4M | ||
| Q2 25 | $165.2M | $72.1M | ||
| Q1 25 | $118.1M | $76.1M | ||
| Q4 24 | $137.0M | $37.2M | ||
| Q3 24 | $137.0M | $41.4M | ||
| Q2 24 | $93.2M | $52.8M |
| Q1 26 | — | — | ||
| Q4 25 | 82.6% | 49.1% | ||
| Q3 25 | 84.4% | 47.1% | ||
| Q2 25 | 85.8% | 47.0% | ||
| Q1 25 | 81.7% | 47.5% | ||
| Q4 24 | 85.9% | 48.2% | ||
| Q3 24 | 83.0% | 46.5% | ||
| Q2 24 | 82.9% | 46.8% |
| Q1 26 | — | 17.1% | ||
| Q4 25 | -20.6% | 17.4% | ||
| Q3 25 | 61.5% | 17.3% | ||
| Q2 25 | 62.2% | 14.2% | ||
| Q1 25 | 53.4% | 15.2% | ||
| Q4 24 | 58.9% | 13.1% | ||
| Q3 24 | 56.3% | 13.5% | ||
| Q2 24 | 50.7% | 15.7% |
| Q1 26 | — | 11.2% | ||
| Q4 25 | -31.3% | 16.5% | ||
| Q3 25 | 49.5% | 13.1% | ||
| Q2 25 | 50.7% | 9.5% | ||
| Q1 25 | 44.6% | 10.8% | ||
| Q4 24 | 46.0% | 5.6% | ||
| Q3 24 | 47.2% | 6.0% | ||
| Q2 24 | 40.3% | 7.9% |
| Q1 26 | — | $0.39 | ||
| Q4 25 | $-1.13 | $0.55 | ||
| Q3 25 | $1.43 | $0.45 | ||
| Q2 25 | $1.33 | $0.32 | ||
| Q1 25 | $0.93 | $0.34 | ||
| Q4 24 | $1.06 | $0.17 | ||
| Q3 24 | $1.05 | $0.19 | ||
| Q2 24 | $0.72 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $120.0M |
| Total DebtLower is stronger | $2.1B | $1.5B |
| Stockholders' EquityBook value | $48.8M | $3.2B |
| Total Assets | $2.5B | $8.1B |
| Debt / EquityLower = less leverage | 43.89× | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $120.0M | ||
| Q4 25 | $133.8M | $204.8M | ||
| Q3 25 | $419.7M | $218.9M | ||
| Q2 25 | $61.9M | $175.5M | ||
| Q1 25 | $176.3M | $59.0M | ||
| Q4 24 | $115.8M | $10.9M | ||
| Q3 24 | $154.3M | $120.9M | ||
| Q2 24 | $187.9M | $34.5M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.5B | $1.7B | ||
| Q2 24 | $1.5B | $1.8B |
| Q1 26 | — | $3.2B | ||
| Q4 25 | $48.8M | $3.1B | ||
| Q3 25 | $503.9M | $3.0B | ||
| Q2 25 | $332.7M | $2.9B | ||
| Q1 25 | $482.3M | $2.7B | ||
| Q4 24 | $363.8M | $2.6B | ||
| Q3 24 | $452.7M | $2.6B | ||
| Q2 24 | $289.4M | $2.4B |
| Q1 26 | — | $8.1B | ||
| Q4 25 | $2.5B | $8.0B | ||
| Q3 25 | $2.2B | $7.8B | ||
| Q2 25 | $2.1B | $7.6B | ||
| Q1 25 | $2.2B | $7.3B | ||
| Q4 24 | $2.1B | $7.2B | ||
| Q3 24 | $2.1B | $7.2B | ||
| Q2 24 | $2.0B | $7.1B |
| Q1 26 | — | 0.46× | ||
| Q4 25 | 43.89× | 0.48× | ||
| Q3 25 | 3.00× | 0.51× | ||
| Q2 25 | 4.54× | 0.53× | ||
| Q1 25 | 3.13× | 0.56× | ||
| Q4 24 | 4.14× | 0.59× | ||
| Q3 24 | 3.32× | 0.64× | ||
| Q2 24 | 5.19× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | $198.8M |
| Free Cash FlowOCF − Capex | $217.6M | $-61.2M |
| FCF MarginFCF / Revenue | 48.2% | -7.8% |
| Capex IntensityCapex / Revenue | 0.3% | 26.0% |
| Cash ConversionOCF / Net Profit | — | 2.26× |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | $-123.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $198.8M | ||
| Q4 25 | $219.0M | $239.9M | ||
| Q3 25 | $178.6M | $251.1M | ||
| Q2 25 | $99.7M | $195.7M | ||
| Q1 25 | $154.2M | $183.9M | ||
| Q4 24 | $178.5M | $163.1M | ||
| Q3 24 | $115.4M | $151.1M | ||
| Q2 24 | $55.8M | $170.4M |
| Q1 26 | — | $-61.2M | ||
| Q4 25 | $217.6M | $-64.6M | ||
| Q3 25 | $175.6M | $28.6M | ||
| Q2 25 | $98.1M | $-26.3M | ||
| Q1 25 | $153.3M | $41.4M | ||
| Q4 24 | $175.4M | $26.8M | ||
| Q3 24 | $113.9M | $64.0M | ||
| Q2 24 | $53.2M | $26.1M |
| Q1 26 | — | -7.8% | ||
| Q4 25 | 48.2% | -8.7% | ||
| Q3 25 | 49.6% | 3.7% | ||
| Q2 25 | 30.1% | -3.5% | ||
| Q1 25 | 57.9% | 5.9% | ||
| Q4 24 | 58.9% | 4.0% | ||
| Q3 24 | 39.3% | 9.2% | ||
| Q2 24 | 23.0% | 3.9% |
| Q1 26 | — | 26.0% | ||
| Q4 25 | 0.3% | 40.9% | ||
| Q3 25 | 0.9% | 28.4% | ||
| Q2 25 | 0.5% | 29.2% | ||
| Q1 25 | 0.4% | 20.2% | ||
| Q4 24 | 1.0% | 20.6% | ||
| Q3 24 | 0.5% | 12.6% | ||
| Q2 24 | 1.1% | 21.6% |
| Q1 26 | — | 2.26× | ||
| Q4 25 | — | 1.95× | ||
| Q3 25 | 1.02× | 2.45× | ||
| Q2 25 | 0.60× | 2.71× | ||
| Q1 25 | 1.31× | 2.41× | ||
| Q4 24 | 1.30× | 4.39× | ||
| Q3 24 | 0.84× | 3.65× | ||
| Q2 24 | 0.60× | 3.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
LTH
| Center revenue | $767.6M | 97% |
| Other revenue | $21.1M | 3% |
